Vivos Therapeutics VVOS Gains 45 as Stock Tests Key Resistance at 073 Patagonia Trademark Dispute with Pattie Gonia Raises Questions on Brand Trust and Allyship MGRX Q3 2025 Earnings EPS Deeply Negative as Stock Falls on Sparse Disclosure OpenAI May Lead AI IPO Race with Confidential Filing Sources Suggest